Assessing the gene-disease association of 19 genes with the RASopathies using the ClinGen gene curation framework

Andrew R Grant, Brandon J Cushman, Hélène Cavé, Mitchell W Dillon, Bruce D Gelb, Karen W Gripp, Jennifer A Lee, Heather Mason-Suares, Katherine A Rauen, Marco Tartaglia, Lisa M Vincent, Martin Zenker

Research output: Contribution to journalArticle

Abstract

The RASopathies are a complex group of conditions regarding phenotype and genetic etiology. The ClinGen RASopathy Expert Panel (RAS EP) assessed published and other publicly available evidence supporting the association of 19 genes with RASopathy conditions. Using the semiquantitative literature curation method developed by the ClinGen Gene Curation Working Group, evidence for each gene was curated and scored for Noonan syndrome (NS), Costello syndrome, cardiofaciocutaneous syndrome, NS with multiple lentigines, and Noonan-like syndrome with loose anagen hair. The curated evidence supporting each gene-disease relationship was then discussed and approved by the ClinGen RASopathy Expert Panel. Each association's strength was classified as definitive, strong, moderate, limited, disputed, or no evidence. Eleven genes were classified as definitively associated with at least one RASopathy condition. Two genes classified as strong for association with at least one RASopathy condition while one gene was moderate and three were limited. The RAS EP also disputed the association of two genes for all RASopathy conditions. Overall, our results provide a greater understanding of the different gene-disease relationships within the RASopathies and can help in guiding and directing clinicians, patients, and researchers who are identifying variants in individuals with a suspected RASopathy.

Original languageEnglish
Pages (from-to)1485-1493
Number of pages9
JournalHuman Mutation
Volume39
Issue number11
DOIs
Publication statusPublished - Nov 2018

Fingerprint

Genes
Costello Syndrome
LEOPARD Syndrome
Noonan Syndrome
Research Personnel
Phenotype

Cite this

Grant, A. R., Cushman, B. J., Cavé, H., Dillon, M. W., Gelb, B. D., Gripp, K. W., ... Zenker, M. (2018). Assessing the gene-disease association of 19 genes with the RASopathies using the ClinGen gene curation framework. Human Mutation, 39(11), 1485-1493. https://doi.org/10.1002/humu.23624

Assessing the gene-disease association of 19 genes with the RASopathies using the ClinGen gene curation framework. / Grant, Andrew R; Cushman, Brandon J; Cavé, Hélène; Dillon, Mitchell W; Gelb, Bruce D; Gripp, Karen W; Lee, Jennifer A; Mason-Suares, Heather; Rauen, Katherine A; Tartaglia, Marco; Vincent, Lisa M; Zenker, Martin.

In: Human Mutation, Vol. 39, No. 11, 11.2018, p. 1485-1493.

Research output: Contribution to journalArticle

Grant, AR, Cushman, BJ, Cavé, H, Dillon, MW, Gelb, BD, Gripp, KW, Lee, JA, Mason-Suares, H, Rauen, KA, Tartaglia, M, Vincent, LM & Zenker, M 2018, 'Assessing the gene-disease association of 19 genes with the RASopathies using the ClinGen gene curation framework', Human Mutation, vol. 39, no. 11, pp. 1485-1493. https://doi.org/10.1002/humu.23624
Grant, Andrew R ; Cushman, Brandon J ; Cavé, Hélène ; Dillon, Mitchell W ; Gelb, Bruce D ; Gripp, Karen W ; Lee, Jennifer A ; Mason-Suares, Heather ; Rauen, Katherine A ; Tartaglia, Marco ; Vincent, Lisa M ; Zenker, Martin. / Assessing the gene-disease association of 19 genes with the RASopathies using the ClinGen gene curation framework. In: Human Mutation. 2018 ; Vol. 39, No. 11. pp. 1485-1493.
@article{2b87c483f8754b639665e67abccecffb,
title = "Assessing the gene-disease association of 19 genes with the RASopathies using the ClinGen gene curation framework",
abstract = "The RASopathies are a complex group of conditions regarding phenotype and genetic etiology. The ClinGen RASopathy Expert Panel (RAS EP) assessed published and other publicly available evidence supporting the association of 19 genes with RASopathy conditions. Using the semiquantitative literature curation method developed by the ClinGen Gene Curation Working Group, evidence for each gene was curated and scored for Noonan syndrome (NS), Costello syndrome, cardiofaciocutaneous syndrome, NS with multiple lentigines, and Noonan-like syndrome with loose anagen hair. The curated evidence supporting each gene-disease relationship was then discussed and approved by the ClinGen RASopathy Expert Panel. Each association's strength was classified as definitive, strong, moderate, limited, disputed, or no evidence. Eleven genes were classified as definitively associated with at least one RASopathy condition. Two genes classified as strong for association with at least one RASopathy condition while one gene was moderate and three were limited. The RAS EP also disputed the association of two genes for all RASopathy conditions. Overall, our results provide a greater understanding of the different gene-disease relationships within the RASopathies and can help in guiding and directing clinicians, patients, and researchers who are identifying variants in individuals with a suspected RASopathy.",
author = "Grant, {Andrew R} and Cushman, {Brandon J} and H{\'e}l{\`e}ne Cav{\'e} and Dillon, {Mitchell W} and Gelb, {Bruce D} and Gripp, {Karen W} and Lee, {Jennifer A} and Heather Mason-Suares and Rauen, {Katherine A} and Marco Tartaglia and Vincent, {Lisa M} and Martin Zenker",
note = "{\circledC} 2018 Wiley Periodicals, Inc.",
year = "2018",
month = "11",
doi = "10.1002/humu.23624",
language = "English",
volume = "39",
pages = "1485--1493",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "John Wiley and Sons Inc.",
number = "11",

}

TY - JOUR

T1 - Assessing the gene-disease association of 19 genes with the RASopathies using the ClinGen gene curation framework

AU - Grant, Andrew R

AU - Cushman, Brandon J

AU - Cavé, Hélène

AU - Dillon, Mitchell W

AU - Gelb, Bruce D

AU - Gripp, Karen W

AU - Lee, Jennifer A

AU - Mason-Suares, Heather

AU - Rauen, Katherine A

AU - Tartaglia, Marco

AU - Vincent, Lisa M

AU - Zenker, Martin

N1 - © 2018 Wiley Periodicals, Inc.

PY - 2018/11

Y1 - 2018/11

N2 - The RASopathies are a complex group of conditions regarding phenotype and genetic etiology. The ClinGen RASopathy Expert Panel (RAS EP) assessed published and other publicly available evidence supporting the association of 19 genes with RASopathy conditions. Using the semiquantitative literature curation method developed by the ClinGen Gene Curation Working Group, evidence for each gene was curated and scored for Noonan syndrome (NS), Costello syndrome, cardiofaciocutaneous syndrome, NS with multiple lentigines, and Noonan-like syndrome with loose anagen hair. The curated evidence supporting each gene-disease relationship was then discussed and approved by the ClinGen RASopathy Expert Panel. Each association's strength was classified as definitive, strong, moderate, limited, disputed, or no evidence. Eleven genes were classified as definitively associated with at least one RASopathy condition. Two genes classified as strong for association with at least one RASopathy condition while one gene was moderate and three were limited. The RAS EP also disputed the association of two genes for all RASopathy conditions. Overall, our results provide a greater understanding of the different gene-disease relationships within the RASopathies and can help in guiding and directing clinicians, patients, and researchers who are identifying variants in individuals with a suspected RASopathy.

AB - The RASopathies are a complex group of conditions regarding phenotype and genetic etiology. The ClinGen RASopathy Expert Panel (RAS EP) assessed published and other publicly available evidence supporting the association of 19 genes with RASopathy conditions. Using the semiquantitative literature curation method developed by the ClinGen Gene Curation Working Group, evidence for each gene was curated and scored for Noonan syndrome (NS), Costello syndrome, cardiofaciocutaneous syndrome, NS with multiple lentigines, and Noonan-like syndrome with loose anagen hair. The curated evidence supporting each gene-disease relationship was then discussed and approved by the ClinGen RASopathy Expert Panel. Each association's strength was classified as definitive, strong, moderate, limited, disputed, or no evidence. Eleven genes were classified as definitively associated with at least one RASopathy condition. Two genes classified as strong for association with at least one RASopathy condition while one gene was moderate and three were limited. The RAS EP also disputed the association of two genes for all RASopathy conditions. Overall, our results provide a greater understanding of the different gene-disease relationships within the RASopathies and can help in guiding and directing clinicians, patients, and researchers who are identifying variants in individuals with a suspected RASopathy.

U2 - 10.1002/humu.23624

DO - 10.1002/humu.23624

M3 - Article

C2 - 30311384

VL - 39

SP - 1485

EP - 1493

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 11

ER -